Cumberland Drug Patent Portfolio

Cumberland owns 4 orange book drugs protected by 13 US patents Given below is the list of Cumberland's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7531623 Hydrochloride salts of a glycopeptide phosphonate derivative 01 Jan, 2027
Active
US7608282 Transdermal granisetron 22 Jan, 2025
Active
US6635618 Glycopeptide phosphonate derivatives 11 Sep, 2023 Expired
US6858584 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 24 Aug, 2022 Expired
US6872701 Glycopeptide phosphonate derivatives 05 Jun, 2021 Expired
US7008923 Glycopeptide phosphonate derivatives 06 May, 2021 Expired
US7208471 Glycopeptide phosphonate derivatives 01 May, 2021 Expired
US7351691 Glycopeptide phosphonate derivatives 01 May, 2021 Expired
US7544364 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 01 May, 2021 Expired
US7700550 Glycopeptide phosphonate derivatives 01 May, 2021 Expired
US8101575 Glycopeptide phosphonate derivatives 01 May, 2021 Expired
US8158580 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 01 May, 2021 Expired
US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof 15 Dec, 2019 Expired


Given below is the list of recent legal activities going on the following drug patents of Cumberland.

Activity Date Patent Number
Patent litigations
Expire Patent 20 May, 2024 US8158580
Expire Patent 26 Feb, 2024 US8101575
Maintenance Fee Reminder Mailed 04 Dec, 2023 US8158580
Maintenance Fee Reminder Mailed 11 Sep, 2023 US8101575
Expire Patent 23 May, 2022 US7700550
Maintenance Fee Reminder Mailed 06 Dec, 2021 US7700550
Payment of Maintenance Fee, 12th Year, Large Entity 14 Apr, 2021 US7608282 (Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 24 Sep, 2020 US7544364
Payment of Maintenance Fee, 12th Year, Large Entity 24 Sep, 2020 US7531623
Payment of Maintenance Fee, 8th Year, Large Entity 04 Oct, 2019 US8158580
Payment of Maintenance Fee, 12th Year, Large Entity 20 Sep, 2019 US7351691
Payment of Maintenance Fee, 8th Year, Large Entity 11 Jul, 2019 US8101575
Payment of Maintenance Fee, 12th Year, Large Entity 24 Oct, 2018 US7208471
Payment of Maintenance Fee, 8th Year, Large Entity 20 Oct, 2017 US7700550
Payment of Maintenance Fee, 12th Year, Large Entity 07 Sep, 2017 US7008923


Cumberland Drug Patents' Oppositions Filed in EPO

Cumberland drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Apr 30, 2008, by Boeters & Lieck. This opposition was filed on patent number EP04708393A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP04708393A Apr, 2008 Harrison Goddard Foote Opposition rejected
EP04708393A Apr, 2008 BOETERS & LIECK Opposition rejected


Cumberland's Family Patents

Cumberland drugs have patent protection in a total of 41 countries. It's US patent count contributes only to 26.9% of its total global patent coverage. 14 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Cumberland Drug List

Given below is the complete list of Cumberland's drugs and the patents protecting them.


1. Sancuso

Sancuso is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7608282 Transdermal granisetron 22 Jan, 2025
(3 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sancuso's drug page


2. Vaprisol

Vaprisol is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof 15 Dec, 2019
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vaprisol's drug page


3. Vaprisol In 5% Dextrose In Plastic Container

Vaprisol In 5% Dextrose In Plastic Container is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof 15 Dec, 2019
(4 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vaprisol In 5% Dextrose In Plastic Container's drug page


4. Vibativ

Vibativ is protected by 11 patents, out of which 10 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7531623 Hydrochloride salts of a glycopeptide phosphonate derivative 01 Jan, 2027
(2 years from now)
Active
US6635618 Glycopeptide phosphonate derivatives 11 Sep, 2023
(1 year, 1 month ago)
Expired
US6858584 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 24 Aug, 2022
(2 years ago)
Expired
US6872701 Glycopeptide phosphonate derivatives 05 Jun, 2021
(3 years ago)
Expired
US7008923 Glycopeptide phosphonate derivatives 06 May, 2021
(3 years ago)
Expired
US7208471 Glycopeptide phosphonate derivatives 01 May, 2021
(3 years ago)
Expired
US7351691 Glycopeptide phosphonate derivatives 01 May, 2021
(3 years ago)
Expired
US7544364 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 01 May, 2021
(3 years ago)
Expired
US7700550 Glycopeptide phosphonate derivatives 01 May, 2021
(3 years ago)
Expired
US8101575 Glycopeptide phosphonate derivatives 01 May, 2021
(3 years ago)
Expired
US8158580 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin 01 May, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vibativ's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List